Sandra N Freiberger

8PUBLICATIONS
31CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical mycologyMedical biotechnology diagnostics (incl. biosensors)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 28, 2026
Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.

Andrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque

|Dec 12, 2025
Circulating Tumor DNA Is Prognostic of Patient Outcome and Enables Therapy Monitoring in Metastatic Uveal Melanoma.

Egle Ramelyte, Julian Kött, Aleigha R Lawless

|Aug 24, 2023
Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype.

Stefanie Hiltbrunner, Lena Cords, Sabrina Kasser

Pageof 2